Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer’s Disease

Reduced Levels of miR-342-5p in Plasma Are Associated With Worse Cognitive Evolution in Patients With Mild Alzheimer’s Disease

BackgroundProgressive cognitive decline is the most relevant clinical symptom of Alzheimer’s disease (AD). However, the rate of cognitive decline is highly variable between patients. Synaptic deficits are the neuropathological event most correlated with cognitive impairment in AD. Considering the im...

Full description

Bibliographic Details
Main Authors: Farida Dakterzada, Iván David Benítez, Adriano Targa, Albert Lladó, Gerard Torres, Leila Romero, David de Gonzalo-Calvo, Anna Moncusí-Moix, Adria Tort-Merino, Raquel Huerto, Manuel Sánchez-de-la-Torre, Ferran Barbé, Gerard Piñol-Ripoll
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Aging Neuroscience
Subjects:
Alzheimer’s disease
cognitive decline
miRNA
miR-342-5p
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2021.705989/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2021.705989/full

Similar Items